glp-1 news today 2025 november The medical cycle was anything but quiet. ⬇️ The Trump administration's significant changes to U.S. healthcare policy dominated headlines in 2025 and comprised many of MedPage Today's most-read stories. In GLP-1 Trends Informing Holistic Kidney

Healthcare providers may consider slower titration or temporarily maintaining a lower dose while monitoring side effects, but any dosing changes should be clinically supervised

GLP-1 injections are typically recommended for individuals who are struggling with obesity or being overweight

IFSO consensus on definitions and clinical practice guidelines for obesity management-an international Delphi study

It is also unclear whether generic entry will be subject to any restrictions imposed by Novo Nordisk, such as volume limited distribution over a period of time

Post-Sepsis Syndrome Even after a patient receives the appropriate treatment for their sepsis, the medical condition still has lingering effects in many cases

Yes, we talk about insurance coverage (thats the stickiest part of all this) and we look ahead to when that might get easier